Utilising (S)‐WAY 100135 and Tropisetron, antagonists of 5‐HT1A and 5‐HT3 receptors respectively, we show that running recovers 5‐HT1A receptor activity lost by CRS. This evidence concerns the gene HTR1A and congenital rubella syndrome.